{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T21:00:39Z","timestamp":1794258039650,"version":"4.9.0"},"reference-count":56,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T00:00:00Z","timestamp":1546992000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2019,2]]},"abstract":"<jats:title>Summary<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Faecal microbiota transplantation (<jats:styled-content style=\"fixed-case\">FMT<\/jats:styled-content>) is effective for <jats:italic>Clostridium difficile<\/jats:italic> infections (<jats:styled-content style=\"fixed-case\">CDI<\/jats:styled-content>) refractory to standard treatment and is being studied in other diseases.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>To evaluate donor characteristics, procedures and clinical outcomes of <jats:styled-content style=\"fixed-case\">FMT<\/jats:styled-content>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We systematically reviewed <jats:styled-content style=\"fixed-case\">FMT<\/jats:styled-content> studies published up to 29 August 2018 using <jats:styled-content style=\"fixed-case\">MEDLINE<\/jats:styled-content> (R) and <jats:styled-content style=\"fixed-case\">EMBASE<\/jats:styled-content> and identified clinical studies with <jats:styled-content style=\"fixed-case\">FMT<\/jats:styled-content> donor information. We reported data on donor characteristics, screening criteria, administration, clinical outcomes and adverse events.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among 5267 reports, 239 full\u2010text articles were screened and 168 articles were included. <jats:styled-content style=\"fixed-case\">FMT<\/jats:styled-content> was performed commonly for <jats:styled-content style=\"fixed-case\">CDI<\/jats:styled-content> (n\u00a0=\u00a0108) and inflammatory bowel disease (<jats:styled-content style=\"fixed-case\">IBD<\/jats:styled-content>) (n\u00a0=\u00a031). We reported characteristics of 1513 donors [58% male; mean age, 34.3\u00a0years; mean body mass index, 21.6]. Donors in Asia were younger than the West (mean age 30.7 vs 32.9, <jats:italic>P<\/jats:italic>\u00a0=\u00a00.00075). Less than 50% of studies screened donors for transmittable pathogens. Final cure rate for <jats:styled-content style=\"fixed-case\">CDI<\/jats:styled-content> was 95.6% (95% confidence interval [<jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>], 93.9%\u201097.1%) and final remission rates for ulcerative colitis (<jats:styled-content style=\"fixed-case\">UC<\/jats:styled-content>) and Crohn's disease (<jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>) were 39.6% (95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>, 25.4%\u201054.6%) and 47.5% (95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>, 29.4%\u201065.8%), respectively. Cure rates in <jats:styled-content style=\"fixed-case\">CDI<\/jats:styled-content> and final remission rates for <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">UC<\/jats:styled-content> were comparable across all routes of <jats:styled-content style=\"fixed-case\">FMT<\/jats:styled-content> administration. Overall adverse event incidence was &lt;1%, mostly <jats:styled-content style=\"fixed-case\">GI<\/jats:styled-content>\u2010related. Adverse event rates did not differ significantly between routes of <jats:styled-content style=\"fixed-case\">FMT<\/jats:styled-content> administration or indication.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In a systematic review assessing donor characteristics and <jats:styled-content style=\"fixed-case\">FMT<\/jats:styled-content> efficacy, we observed heterogeneity in donor selection, application and outcomes of <jats:styled-content style=\"fixed-case\">FMT<\/jats:styled-content>. These data can facilitate standardisation of <jats:styled-content style=\"fixed-case\">FMT<\/jats:styled-content> protocols for various diseases.<\/jats:p><\/jats:sec>","DOI":"10.1111\/apt.15116","type":"journal-article","created":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T06:25:51Z","timestamp":1547101551000},"page":"354-363","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":106,"title":["Systematic review with meta\u2010analysis: review of donor features, procedures and outcomes in 168 clinical studies of faecal microbiota transplantation"],"prefix":"10.1111","volume":"49","author":[{"given":"Cheuk Yin","family":"Lai","sequence":"first","affiliation":[{"name":"Department of Medicine and Therapeutics The Chinese University of Hong Kong Hong Kong China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Sung","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics The Chinese University of Hong Kong Hong Kong China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics The Chinese University of Hong Kong Hong Kong China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Whitney","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics The Chinese University of Hong Kong Hong Kong China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunny H.","family":"Wong","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics Institute of Digestive Disease State Key Laboratory of Digestive Disease LKS Institute of Health Sciences The Chinese University of Hong Kong Hong Kong China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul K.S.","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Microbiology The Chinese University of Hong Kong Hong Kong China"},{"name":"Center for Gut Microbiota Research The Chinese University of Hong Kong Hong Kong China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Kamm","sequence":"additional","affiliation":[{"name":"St Vincent's Hospital and University of Melbourne Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph J.Y.","family":"Sung","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics Institute of Digestive Disease State Key Laboratory of Digestive Disease LKS Institute of Health Sciences The Chinese University of Hong Kong Hong Kong China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2719-0556","authenticated-orcid":false,"given":"Gilaad","family":"Kaplan","sequence":"additional","affiliation":[{"name":"Departments of Medicine and Community Health Sciences The University of Calgary Calgary Alberta Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis K.L.","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics Institute of Digestive Disease State Key Laboratory of Digestive Disease LKS Institute of Health Sciences The Chinese University of Hong Kong Hong Kong China"},{"name":"Center for Gut Microbiota Research The Chinese University of Hong Kong Hong Kong China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6850-4454","authenticated-orcid":false,"given":"Siew C.","family":"Ng","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics Institute of Digestive Disease State Key Laboratory of Digestive Disease LKS Institute of Health Sciences The Chinese University of Hong Kong Hong Kong China"},{"name":"Center for Gut Microbiota Research The Chinese University of Hong Kong Hong Kong China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,1,9]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0707500"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir632"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2011.244"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-05-717652"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13868"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30182-4"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.08.058"},{"key":"e_1_2_7_9_1","first-page":"1","volume-title":"Enforcement Policy Regarding Investigational New Drug Requirements for Use of Fecal Microbiota for Transplantation to Treat Clostridium difficile Infection Not Responsive to Standard Therapies","year":"2016"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaq0034"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-313017"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.7326\/M14-2693"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2013.59"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i17.5359"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjx063"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14201"},{"key":"e_1_2_7_17_1","first-page":"634","article-title":"Bacteriophage transfer during faecal microbiota transplantation in Clostridium difficile infection is associated with treatment outcome","volume":"67","author":"Zuo T","year":"2017","journal-title":"Gut"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2011.08.014"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2011.482"},{"key":"e_1_2_7_20_1","unstructured":"Full\u2010Length Donor History Questionnaire (DHQ) 2016; v2.0.http:\/\/www.aabb.org\/tm\/questionnaires\/Pages\/dhqaabb.aspx. Accessed January 21 2018."},{"key":"e_1_2_7_21_1","unstructured":"Study Quality Assessment Tools n.d.https:\/\/www.nhlbi.nih.gov\/health-topics\/study-quality-assessment-tools. Accessed November 1 2018."},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.7326\/M16-2810"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00008.x"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature11053"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1241214"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12550"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000893"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjv203"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-015-2394-x"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2016.08.110"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-016-1271-4"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000405"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gastrohep.2017.03.004"},{"issue":"35","key":"e_1_2_7_34_1","first-page":"583","article-title":"Fecal microbiota transplant in patients with recurrent Clostridium difficile infection","volume":"113","author":"Hagel S","year":"2016","journal-title":"Dtsch Arztebl Int"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13969"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1994.50.705"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9780511545313.054"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00271"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1086\/367657"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.11.037"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1205037"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00006-15"},{"key":"e_1_2_7_43_1","unstructured":"BowenA.Shigellosis. Infectious diseases related to travel 2017;https:\/\/wwwnc.cdc.gov\/travel\/yellowbook\/2018\/infectious-diseases-related-to-travel\/shigellosis. Accessed August 31 2017."},{"key":"e_1_2_7_44_1","unstructured":"O'ReillyCE IwamotoM GriffinPM.Escherichia coli Diarrheagenic. Infectious Diseases Related to Travel 2017.https:\/\/wwwnc.cdc.gov\/travel\/yellowbook\/2018\/infectious-diseases-related-to-travel\/escherichia-coli-diarrheagenic. Accessed August 8 2017."},{"key":"e_1_2_7_45_1","unstructured":"WongKK BurdetteE MintzED.Cholera. Infectious Diseases Related to Travel 2017.https:\/\/wwwnc.cdc.gov\/travel\/yellowbook\/2018\/infectious-diseases-related-to-travel\/cholera. Accessed August 31 2017."},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-0556"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1186\/2049-2618-2-42"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI72333"},{"key":"e_1_2_7_49_1","doi-asserted-by":"publisher","DOI":"10.1038\/ismej.2007.3"},{"key":"e_1_2_7_50_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.14-267690"},{"key":"e_1_2_7_51_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-198800001-00009"},{"key":"e_1_2_7_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2016.09.001"},{"key":"e_1_2_7_53_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-017-0548-y"},{"key":"e_1_2_7_54_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.18098"},{"key":"e_1_2_7_55_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12699"},{"key":"e_1_2_7_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhin.2015.10.024"},{"key":"e_1_2_7_57_1","doi-asserted-by":"publisher","DOI":"10.3109\/00365521.2014.966753"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fapt.15116","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/apt.15116","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T13:37:48Z","timestamp":1694266668000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/apt.15116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,9]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["10.1111\/apt.15116"],"URL":"https:\/\/doi.org\/10.1111\/apt.15116","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,9]]},"assertion":[{"value":"2018-06-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-12-06","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}